Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1992 1
1993 1
1994 1
1995 2
1996 1
1998 1
2000 1
2003 2
2004 1
2008 4
2009 1
2010 4
2011 13
2012 7
2013 1
2014 7
2015 3
2016 6
2017 11
2018 5
2019 7
2020 13
2021 14
2022 18
2023 21
2024 20
2025 23
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Results by year

Filters applied: . Clear all
Page 1
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.
Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, Lopes A, Maury MM, Moura A, Goffinet F, Dieye HB, Thouvenot P, Ungeheuer MN, Tourdjman M, Goulet V, de Valk H, Lortholary O, Ravaud P, Lecuit M; MONALISA study group. Charlier C, et al. Lancet Infect Dis. 2017 May;17(5):510-519. doi: 10.1016/S1473-3099(16)30521-7. Epub 2017 Jan 28. Lancet Infect Dis. 2017. PMID: 28139432 Free article.
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.
Dahan K, Debiec H, Plaisier E, Cachanado M, Rousseau A, Wakselman L, Michel PA, Mihout F, Dussol B, Matignon M, Mousson C, Simon T, Ronco P; GEMRITUX Study Group. Dahan K, et al. J Am Soc Nephrol. 2017 Jan;28(1):348-358. doi: 10.1681/ASN.2016040449. Epub 2016 Jun 27. J Am Soc Nephrol. 2017. PMID: 27352623 Free PMC article. Clinical Trial.
Exome-First Strategy in Adult Patients With CKD: A Cohort Study.
Doreille A, Lombardi Y, Dancer M, Lamri R, Testard Q, Vanhoye X, Lebre AS, Garcia H, Rafat C, Ouali N, Luque Y, Izzedine H, Esteve E, Cez A, Petit-Hoang C, François H, Marchal A, Letavernier E, Frémeaux-Bacchi V, Boffa JJ, Rondeau E, Raymond L, Mesnard L. Doreille A, et al. Among authors: mesnard l. Kidney Int Rep. 2022 Dec 17;8(3):596-605. doi: 10.1016/j.ekir.2022.12.007. eCollection 2023 Mar. Kidney Int Rep. 2022. PMID: 36938085 Free PMC article.
Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies.
Maisons V, Duval A, Mesnard L, Frimat M, Fakhouri F, Grangé S, Servais A, Cartery C, Fauchier L, Coppo P, Titeca-Beauport D, Fage N, Delmas Y, Quérard AH, Seret G, Bobot M, Le Quintrec M, Ville S, von Tokarski F, Chauvet S, Wynckel A, Martins M, Schurder J, Barbet C, Sautenet B, Gatault P, Caillard S, Vuiblet V, Halimi JM; MATRIX Consortium Group. Maisons V, et al. Among authors: mesnard l. Kidney Int. 2024 May;105(5):1100-1112. doi: 10.1016/j.kint.2024.02.014. Epub 2024 Feb 29. Kidney Int. 2024. PMID: 38431217
Comment faciliter la diffusion des tests de pharmacogénétique ?
Verstuyft C, Dewolf D, Blin O, Florentin V, Mesnard L, Chaumette B, Ayme-Dietrich E, Raymond L, Lang M, Lamazière A, Allard B, Samelson L, Lamezec L, Loriot MA, Le Bozec A, Picard N. Verstuyft C, et al. Among authors: mesnard l. Therapie. 2025 Jan-Feb;80(1):93-102. doi: 10.1016/j.therap.2024.11.007. Epub 2024 Dec 5. Therapie. 2025. PMID: 39710540 French. No abstract available.
Vancomycin-Associated Cast Nephropathy.
Luque Y, Louis K, Jouanneau C, Placier S, Esteve E, Bazin D, Rondeau E, Letavernier E, Wolfromm A, Gosset C, Boueilh A, Burbach M, Frère P, Verpont MC, Vandermeersch S, Langui D, Daudon M, Frochot V, Mesnard L. Luque Y, et al. Among authors: mesnard l. J Am Soc Nephrol. 2017 Jun;28(6):1723-1728. doi: 10.1681/ASN.2016080867. Epub 2017 Jan 12. J Am Soc Nephrol. 2017. PMID: 28082518 Free PMC article.
Kidney Transplantation in Patients With AA Amyloidosis: Outcomes in a French Multicenter Cohort.
Schwarz C, Georgin-Lavialle S, Lombardi Y, Marion O, Jambon F, Legendre C, Marx D, Levi C, Toure F, Le Quintrec M, Bobot M, Matignon M, Dujardin A, Maanaoui M, Cuozzo S, Jalal-Eddine A, Louis K, Mohamadou I, Brazier F, De Nattes T, Geneste C, Thervet E, Ducloux D, Mayet V, Kormann R, Lanot A, Duveau A, Zaidan M, Mesnard L, Ouali N, Rondeau E, Petit-Hoang C, Audard V, Deshayes A, Moktefi A, Rabant M, Buob D, François H, Luque Y. Schwarz C, et al. Among authors: mesnard l. Am J Kidney Dis. 2024 Mar;83(3):329-339. doi: 10.1053/j.ajkd.2023.07.020. Epub 2023 Sep 22. Am J Kidney Dis. 2024. PMID: 37741608 Free article. Review.
Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomes.
Joseph A, Harel S, Mesnard L, Rafat C, Knapp S, Rumpler A, Philipponnet C, Barba C, Rebibou JM, Buob D, Hertig A, Vargaftig J, Halimi JM, Arnulf B, Bretaud AS, Joly B, Grangé S, Coppo P. Joseph A, et al. Among authors: mesnard l. Nephrol Dial Transplant. 2024 Nov 27;39(12):2067-2078. doi: 10.1093/ndt/gfae096. Nephrol Dial Transplant. 2024. PMID: 38658194
Predicting Remission in Antiphospholipase A2 Receptor Antibody-Associated Membranous Nephropathy: A Secondary Analysis of the GEMRITUX, MENTOR, and STARMEN Trials.
Barbour SJ, Ronco P, Praga M, Fervenza FC, Induruwage D, Zhu B, Debiec H, Fernández-Juárez G, Caravaca-Fontán F, Cattran DC; GEMRITUX, MENTOR and STARMEN investigators. Barbour SJ, et al. Clin J Am Soc Nephrol. 2025 Apr 14;20(6):854-865. doi: 10.2215/CJN.0000000694. Clin J Am Soc Nephrol. 2025. PMID: 40228233
166 results